Bradley Allen Kreger - 20 May 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Signature
/s/ Bradley Kreger by Nicholas Khadder, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
20 May 2022
Net transactions value
-$29,584
Form type
4
Filing time
23 May 2022, 20:16:31 UTC
Previous filing
24 Feb 2022
Next filing
20 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 +3,125 +3.4% $0.000000 94,433 20 May 2022 Direct
transaction LAB Common Stock Options Exercise $0 +2,237 +2.4% $0.000000 96,670 20 May 2022 Direct
transaction LAB Common Stock Options Exercise $0 +2,391 +2.5% $0.000000 99,061 20 May 2022 Direct
transaction LAB Common Stock Options Exercise $0 +25,000 +25% $0.000000 124,061 20 May 2022 Direct
transaction LAB Common Stock Options Exercise $0 +9,527 +7.7% $0.000000 133,588 20 May 2022 Direct
transaction LAB Common Stock Tax liability $29,584 -14,431 -11% $2.05 119,157 20 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Options Exercise $0 -3,125 -100% $0.000000* 0 20 May 2022 Common Stock 3,125 Direct F1, F2
transaction LAB Restricted Stock Units Options Exercise $0 -2,237 -25% $0.000000 6,711 20 May 2022 Common Stock 2,237 Direct F1, F3
transaction LAB Restricted Stock Units Options Exercise $0 -2,391 -13% $0.000000 16,735 20 May 2022 Common Stock 2,391 Direct F1, F4
transaction LAB Restricted Stock Units Options Exercise $0 -25,000 -50% $0.000000 25,000 20 May 2022 Common Stock 25,000 Direct F1, F5
transaction LAB Restricted Stock Units Options Exercise $0 -9,527 -25% $0.000000 28,584 20 May 2022 Common Stock 9,527 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.
F3 On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F4 On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
F5 On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.
F6 On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.